UV Partners Inc. announces its newest addition to the UV Angel product line designed to actively disinfect mobile technology in hospitals around the clock. With the ongoing healthcare information technology (HIT) national adoption of meaningful use practices, just under 1 million beds in the U.S. are now supported by electronic health records (EHR). The mandate for EHR implementation has introduced many new devices and high-touch surfaces to the patient care cycle including at their bedside. UV Angel’s mission is to continuously and effectively disinfect technology – killing pathogens before they have the opportunity to become healthcare-acquired infections (HAIs).
"After culturing numerous mobile devices in the healthcare environment, electronic medical records (EMR) and mobile technology workflow create clear risk for nosocomial transmissions," says Ted Cole, president, founder and inventor of UV Angel. "Manually disinfecting equipment after every interaction with the patient is an insurmountable task. Hospitals need help reducing bioburden independent of human intervention around the clock." UV Angel’s new devices attach themselves directly to high-touch mobile technology, actively disinfecting around the clock. These mobile fomites include: EMR computer carts, medication dispensing, IV pumps, vital signs monitors, ventilators, and more.
UV Angel devices inactivate microbes by damaging their DNA through a calculated dose of low UV-C energy delivered to its targeted surface. A recent CDC-sponsored study released October 2015 at the IDWeek conference validated the addition of UV-C disinfection to standard cleaning procedures. The study utilized a conservative UV-C dose application of once every three to five days. During this high UV-C compliance utilization period, the study demonstrated about a 30 percent reduction in HAIs.
"What would happen if UV-C was applied 24/7?" asks Cole. "UV Angel can disinfect the most critical surfaces in a patient room 120-200 times in a three-to-five day period—that’s up to 40 times per day—without any staff interaction."
UV Angel disinfects its target surface in an average of 5 minutes and has been tested to disinfect surfaces with deadly—and notoriously hard-to-kill— pathogens like Clostridium difficile (C. diff) and methicillin-resistant Staphylococcus aureus (MRSA) 20 to 40 times per day. UV Angel’s treatment of Carbapenem-resistant Enterobacteriaceae (CRE), Vancomycin-resistant enterococci (VRE), and Klebsiellae pneumoniae (KPC-2) cells result in dramatic inactivation after 2 minutes of exposure.
Source: UV Partners Inc.